Publications
32
Citations
260
Est. group size
~12
Recurring co-author estimate
Active years
6
Publishing since 2021
Sanam Ghazi's research focuses on cardio-oncology, which studies heart-related side effects (cardiotoxicity) caused by cancer treatments such as immune checkpoint inhibitors and tumor-infiltrating lymphocyte therapy. Earlier work also examined outcomes of pituitary gland tumor surgery and, separately, injury epidemiology. Methods used include systematic reviews, meta-analyses, and pharmacovigilance (drug safety) database studies.
Publication output was minimal before 2021, then increased sharply from 2022 to 2024, with continued activity in 2025 and planned outputs for 2026, suggesting a growing and currently active research focus.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- 26-A-19249-ACC MAJOR CARDIOVASCULAR EVENTS IN PATIENTS RECEIVING TUMOR-INFILTRATING LYMPHOCYTE THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF LATTER-PHASE TRIALS
Journal of the American College of Cardiology · 2026
- 26-A-20416-ACC TUMOR-INFILTRATING LYMPHOCYTE CARDIOTOXICITY: A REAL-WORLD PHARMACOVIGILANCE STUDY OF FDA ADVERSE EVENT REPORTING SYSTEM (FAERS)
Journal of the American College of Cardiology · 2026
- Cardiotoxicity prevention trials in the era of contemporary cancer therapies: a systematic review
Cardio-Oncology · 2026
- Characterizing Cardiotoxicity of FDA-Approved Soft Tissue Sarcoma Targeted Therapies and Immune Checkpoint Inhibitors: A Systematic Review
Cancers · 2025
- Abstract 4369783: Clinical Safety Outcomes of ICI Rechallenge following ICI-myocarditis and other Cardiotoxicities
Circulation · 2025
- Health Equity in Cardio-oncology: Investigating Mechanistic Causes Behind Adverse Cardiovascular and Cancer Health
Current Treatment Options in Cardiovascular Medicine · 2024
- Epidemiological pattern and management of dog bite injuries in Karachi, Pakistan: A cross-sectional study
Injury · 2023
- AKU Giant Pituitary Adenoma Score: A Novel Scoring System to Predict the Outcomes of Surgery for Giant Pituitary Adenomas
Cureus · 2022
- Prognostic implication of size on outcomes of pituitary macroadenoma: a comparative analysis of giant adenoma with non-giant macroadenoma
Journal of Neuro-Oncology · 2022
- Giant Pituitary Adenoma (GPA) score: a novel scoring system to predict postoperative outcomes
WFNOS 2022 Abstract Book · 2022
- NCOG-32. PROGNOSTIC IMPLICATIONS OF SIZE OF PITUITARY MACROADENOMAS: A COMPARATIVE ANALYSIS OF GIANT ADENOMAS WITH NON-GIANT MACROADENOMAS
Neuro-Oncology · 2021
- NCOG-31. GIANT PITUITARY ADENOMA (GPA) SCORE: A NOVEL SCORING SYSTEM TO PREDICT POSTOPERATIVE OUTCOMES OF GIANT PITUITARY ADENOMAS
Neuro-Oncology · 2021
- Circulation×7
- Journal of the American College of Cardiology×3
- Neuro-Oncology×2
- JACC CardioOncology×1
- International Journal of Radiation Oncology*Biology*Physics×1
- Onaopepo Kola‐Kehinde
Medicine · The Ohio State University
- Patrick Ruz
Medicine · The Ohio State University
- Daniel Addison
Medicine · The Ohio State University
- Adam S. Potter
Medicine · The Ohio State University
- Adnan Shaaban
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile